NCT01231269View on ClinicalTrials.gov

Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2025

Conditions
LymphomaHodgkin LymphomaNon-Hodgkin Lymphoma (Follicular, Diffuse B-cel Lymphoma, PTLD and Mantle Cel Lymphoma)
Interventions
OTHER

MRI

MRI scan without administration of contrast/without radiation

Trial Locations (1)

3000

University Hospital Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT01231269 - Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma | Biotech Hunter | Biotech Hunter